Denali Therapeutics to Give Opening Plenary Address at Alzheimer’s Association International Conference (AAIC) 2026 and Highlight Breakthroughs in Delivering Biologic Therapies Across Blood-Brain Ba

Go back to Denali Therapeutics to Give Opening Plenary Address at Alzheimer’s Association International Conference (AAIC) 2026 and Highlight Breakthroughs in Delivering Biologic Therapies Across Blood-Brain Ba
(NASDAQ: DNLI) Delayed: 22.08 --0 (-0%)
Previous Close $22.08    52 Week High
Open $22.08    52 Week Low
Day High $22.08    P/E N/A 
Day Low $22.08    EPS
Volume 1,612